NeuroOne Medical Technologies Corporation (NASDAQ: NMTC)
Neuro One develops neuromonitoring and neuromodulating technologies to treat disorders of the brain, spinal cord, and peripheral nerves. The startup provides evidence-based medical and surgical interventions, enhancing patient outcomes in complex neurological cases.
- Digital Health
- Healthcare Technology
Funding
Raised to date
$8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Disorders affecting the brain, spinal cord, and peripheral nerves often require complex medical and surgical interventions. Patients need comprehensive care that integrates advanced techniques and technologies for accurate diagnosis, treatment, and rehabilitation.
Solution
Neuro One is a center of excellence that provides comprehensive neurological care, offering advanced techniques to treat disorders of the brain, spinal cord, spine, and peripheral nerves. The center delivers neurology, neurosurgery, spine surgery, neuro-oncology, endoscopic surgery, skull base surgery, neuroradiology, neuropsychology, and neuro-rehabilitation services. Neuro One employs a multidisciplinary approach, integrating advanced technologies and a team of specialists to ensure optimal, evidence-based treatment and rehabilitation.
Target Audience
The primary audience includes individuals suffering from disorders of the brain, spinal cord, and peripheral nerves, as well as referring physicians seeking specialized neurological care for their patients.
Features
- Comprehensive neurology and neurosurgery services for a wide range of conditions.
- Advanced neuro-diagnostic imaging, including neuro-radiology.
- Minimally invasive surgical options, including endoscopic and skull base surgery.
- Dedicated neuro-rehabilitation programs.
- Pain management services.
- Neuropsychiatry services.
- Neuro-critical care unit for acute neurological conditions.